PHOENIX MOLECULAR DESIGNS
Phoenix Molecular Designs is developing precise cancer therapeutics with a platform technology focused on developing first-in-class kinase inhibitors designed to uniquely target p90 ribosomal S6 kinase (RSK). Their world-renowned leadership team boasts over 100 years of oncology experience from notable affiliations such as Genentech, Pfizer and Eli Lily. The company completed a Phase 1 first-in-human clinical trial with lead asset, PMD-026, as of Oct 2020, treating women with metastatic breast cancer. A Phase 1b mono-therapy trial is now open in triple negative breast cancer (TNBC) in 9 leading medical centers across the United States.
PHOENIX MOLECULAR DESIGNS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.phoenixmd.ca
Total Employee:
11+
Status:
Active
Contact:
+1 604 674 1796
Email Addresses:
[email protected]
Total Funding:
12.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema Google Apps For Business
Current Advisors List
Current Employees Featured
Founder
Investors List
The 51 Ventures
The 51 Ventures investment in Seed Round - Phoenix Molecular Designs
Pallasite Ventures
Pallasite Ventures investment in Seed Round - Phoenix Molecular Designs
World Changing Ventures
World Changing Ventures investment in Seed Round - Phoenix Molecular Designs
Pallasite Ventures
Pallasite Ventures investment in Seed Round - Phoenix Molecular Designs
Official Site Inspections
http://www.phoenixmd.ca Semrush global rank: 7.66 M Semrush visits lastest month: 447
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "Phoenix Molecular Designs"
About Us - Phoenix Molecular Designs
A Letter from The Founders โAs part of your journey, we strive to uphold the same precise, high level of care that we would wish for our own family.See details»
Phoenix Molecular Designs - Crunchbase Company โฆ
Dec 20, 2018 Contact Email [email protected] Phone Number +1 604 674 1796 Phoenix Molecular Designs is developing precise cancer therapeutics with a platform technology focused on developing first-in-class kinase inhibitors โฆSee details»
Management Team - Phoenix Molecular Designs
Her broad range of experience in private industry, government and academia has prepared her to lead PhoenixMD, where they are working to change the outcomes for women with breast โฆSee details»
Canadian biotech firm making strides in the fight โฆ
Canadian biotech firm making strides in the fight against breast cancer. Chief Executive Officer Dr. Sandi Dunn and her team at Phoenix Molecular Designs (PhoenixMD) are breaking new ground in the treatment of tripleโnegative โฆSee details»
Phoenix Molecular Designs - Overview, News & Similar ... - ZoomInfo
Phoenix Molecular Designs contact info: Phone number: (604) 674-1796 Website: www.phoenixmd.ca What does Phoenix Molecular Designs do? PhoenixMD is a privately-held โฆSee details»
Phoenix Molecular Designs - Craft
Vancouver, BC HQ. Canada. 887 Great Northern Way suite 220. San Diego, CA. United States. 3210 Merryfield Row. Vancouver, BC. Canada. 1-8755 Ash StSee details»
Phoenix Molecular Designs Appoints Biotech โฆ
Mar 29, 2021 PhoenixMD has clinical headquarters in San Diego, CA, and pre-clinical operations in Vancouver, BC. For more information, visit phoenixmd.ca SOURCE Phoenix Molecular DesignsSee details»
Phoenix Molecular Designs, 8755 Ash St, Vancouver, BC V6P 6T3, โฆ
Https://phoenixmd.ca Phoenix Molecular Designs is a biotechnology company based in San Diego, CA, specializing in personalized and alternative cancer therapeutics. With a focus on โฆSee details»
Phoenix Molecular Designs Appoints Magda Marquet, Ph.D. to its โฆ
VANCOUVER, BC and SAN DIEGO, CA. - Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics bySee details»
Advisory Board - Phoenix Molecular Designs
In 2005, he was recruited to Genentech, the US based R&D organization in Roche, to expand the organizationโs drug discovery capabilities to include small molecules. Focused on agility and pioneering science, Mike built a team โฆSee details»
About PHOENIX MOLECULAR DESIGNS | DxMultiomics
PhoenixMD has clinical headquarters in San Diego, CA, and preclinical operations in Vancouver, BC. Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b โฆSee details»
Phoenix Molecular Designs Raises $2.7M To Develop PMD-026
Sep 18, 2018 VANCOUVER, British Columbia and SAN DIEGO, Sept. 18, 2018 /CNW/ -- Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing โฆSee details»
Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael โฆ
Mar 29, 2021 SAN DIEGO, California and VANCOUVER, BC, March 29, 2021 /PRNewswire/ - Phoenix Molecular Designs ( PhoenixMD ), a company on a mission to help thousands of โฆSee details»
Sandra Dunn - Phoenix Molecular Designs - LinkedIn
I am passionate about ending the suffering from breast cancer because of the impact itโฆ · Experience: Phoenix Molecular Designs · Education: North Carolina State University · โฆSee details»
Nick Sharp - Phoenix Molecular Designs - LinkedIn
We comprise over 25 Doctors in total, the majority of whom are board-certified veterinary specialists. <br><br>I am also a board member at Phoenix Molecular Designs โฆSee details»
Mission & Vision โ Phoenix Molecular Designs
Phoenix Molecular Designs is a female-founded company led by experts in breast cancer, who have dedicated decades of their lives to developing new therapies for patients and their families.See details»
Sandra Dunn - Chief Execut.. - Phoenix Molecular Designs
View Sandra Dunn's business profile as Chief Executive Officer at Phoenix Molecular Designs. Find contact's direct phone number, email address, work history, and more.See details»
Home | Phoenix
© 2019 by The Minjin Project. bottom of pageSee details»
Media - Phoenix Molecular Designs
Sep 3, 2024 SAN DIEGO, California - VANCOUVER, British Columbia, September 6, 2023 - Phoenix Molecular Designs (PhoenixMD), a leading clinical-stage therapeutics company โฆSee details»
Londoner recognized with Order of Ontario for work helping
2 hours ago The longtime head of a London-based non-profit helping those with complex medical and developmental needs live in their own communities is one of 29 people appointed โฆSee details»